(Q70022004)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949057%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

title

On central effects of serotonin re-uptake inhibitors: quantitative EEG and psychometric studies with sertraline and zimelidine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949057%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference

B Saletu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949057%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

J Grünberger

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949057%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

L Linzmayer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949057%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949057%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

number of pages

26

1 reference

inferred from page(s)

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949057%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

page(s)

241-266

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949057%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949057%20AND%20SRC:MED&resulttype=core&format=json

Fluvoxamine as an antidepressant drug

7 October 2019

cites work

1 reference

12 December 2020

A double-blind evaluation of zimelidine in comparison to placebo and amitmptyline in patients with major depressive disorder

1 reference

12 December 2020

Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

1 reference

12 December 2020

Long-term study of fluvoxamine: a new rapid-acting antidepressant

1 reference

12 December 2020

Abnormalities of indoleamines in affective disorders.

1 reference

12 December 2020

[Clinical psychodiagnosis using psychophysiologic procedures]

1 reference

12 December 2020

The use of the EEG for assessment of vigilance changes caused by beta-blockers.

1 reference

12 December 2020

Biochemical post-mortem findings in depressed patients

1 reference

12 December 2020

The new generation of antidepressants

1 reference

12 December 2020

The effect of nisoxetine (Lilly compound 94939), a potential antidepressant, on biogenic amine uptake in man

1 reference

12 December 2020

Fluvoxamine?A new serotonin re-uptake inhibitor: First clinical and psychometric experiences in depressed patients

1 reference

12 December 2020

A scale for the objective evaluation of the state of subjective well-being as a method for longitudinal studies

1 reference

12 December 2020

l-Tryptophan in affective disorders: Indoleamine changes and differential clinical effects

1 reference

12 December 2020

Levels of total and free tryptophan in the plasma of endogenous and neurotic depressives

1 reference

12 December 2020

5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?

1 reference

12 December 2020

Zimelidine: A therapeutic and pharmacokinetic study in depression

1 reference

12 December 2020

L-tryptophan in depression

1 reference

12 December 2020

Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin

1 reference

12 December 2020

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

1 reference

12 December 2020

Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania

1 reference

12 December 2020

Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients

1 reference

12 December 2020

Correlation of individual symptoms and other clinical variables with cerebrospinal fluid amine metabolites and tryptophan in depression

1 reference

12 December 2020

Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses

1 reference

12 December 2020

Tryptophan and depressive illness

1 reference

12 December 2020

Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: Quantitative EEG, psychometric and pharmacokinetic studies in man

1 reference

12 December 2020

Total and non-bound tryptophan in unipolar illness

1 reference

12 December 2020

Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline

1 reference

12 December 2020

5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides

1 reference

12 December 2020

EEG and human psychopharmacology

1 reference

12 December 2020

The Practical Management of Affective Disorders

1 reference

12 December 2020

Determination of pharmacodynamics of psychotropic drugs by psychometric analysis

1 reference

12 December 2020

Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01243351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2949057%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference